These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38735265)

  • 1. Biological impact and therapeutic potential of a novel camptothecin derivative (FLQY2) in pancreatic cancer through inactivation of the PDK1/AKT/mTOR pathway.
    Wang W; Xiong H; Li L; Hu X; Zhuang W; Li J; Sun X; Yu Y; Yu Y; Guo Y; Wang Y; Wang R; Wang H; Li Q
    Bioorg Chem; 2024 Jul; 148():107436. PubMed ID: 38735265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway.
    Zhang X; Zhong S
    Anticancer Agents Med Chem; 2020; 20(7):828-833. PubMed ID: 32188393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism,
    Yamazaki T; Phan ND; Maneenet J; Yamagishi M; Nishikawa Y; Okada T; Okumura T; Toyooka N; Fujii T; Awale S
    J Med Chem; 2024 Aug; 67(16):14313-14328. PubMed ID: 39106150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway.
    Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y
    Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.
    Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S
    Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
    Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer.
    Zhu SL; Qi M; Chen MT; Lin JP; Huang HF; Deng LJ; Zhou XW
    Phytomedicine; 2024 Jun; 128():155377. PubMed ID: 38503154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.
    Lan CY; Chen SY; Kuo CW; Lu CC; Yen GC
    J Food Drug Anal; 2019 Oct; 27(4):887-896. PubMed ID: 31590760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental study of combination therapy with S-1 against pancreatic cancer.
    Yoshizawa J; Takizawa A; Takeuchi O; Hiraku O; Sasaki K; Morimoto Y; Atsuda K; Inoue G; Suzuki Y; Asanuma F; Yamada Y
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1211-9. PubMed ID: 19337733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9.
    Sheng W; Xu W; Ding J; Li L; You X; Wu Y; He Q
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34590156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship and mechanistic study on guggulsterone derivatives; Discovery of new anti-pancreatic cancer candidate.
    Kohyama A; Kim MJ; Yokoyama R; Sun S; Omar AM; Phan ND; Meselhy MR; Tsuge K; Awale S; Matsuya Y
    Bioorg Med Chem; 2022 Jan; 54():116563. PubMed ID: 34942553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
    Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin reduces pancreatic cancer cell proliferation and increases apoptosis through MTOR signaling pathway and its dose-effect relationship.
    Zhao HW; Zhou N; Jin F; Wang R; Zhao JQ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5336-5344. PubMed ID: 32495867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancer.
    Cao R; Song W; Ye C; Liu X; Li L; Li Y; Yao H; Zhou X; Li L; Shao R
    Cancer Med; 2019 Feb; 8(2):643-655. PubMed ID: 30681288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.
    Hirai H; Sootome H; Nakatsuru Y; Miyama K; Taguchi S; Tsujioka K; Ueno Y; Hatch H; Majumder PK; Pan BS; Kotani H
    Mol Cancer Ther; 2010 Jul; 9(7):1956-67. PubMed ID: 20571069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BF12, a Novel Benzofuran, Exhibits Antitumor Activity by Inhibiting Microtubules and the PI3K/Akt/mTOR Signaling Pathway in Human Cervical Cancer Cells.
    Gao Y; Ma C; Feng X; Liu Y; Haimiti X
    Chem Biodivers; 2020 Mar; 17(3):e1900622. PubMed ID: 31951313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts.
    Liu Y; Zhang W; Wang XJ; Liu S
    BMC Complement Altern Med; 2014 Jul; 14():228. PubMed ID: 25005526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway.
    Ma Y; Yang X; Han H; Wen Z; Yang M; Zhang Y; Fu J; Wang X; Yin T; Lu G; Qi J; Lin H; Wang X; Yang Y
    Bioorg Chem; 2021 Jun; 111():104872. PubMed ID: 33838560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K/Akt/mTOR signaling pathways to activate P53 and induce apoptosis.
    Chen NY; Lu K; Yuan JM; Li XJ; Gu ZY; Pan CX; Mo DL; Su GF
    Bioorg Chem; 2021 Sep; 114():105101. PubMed ID: 34175723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.